Randomized, Phase III Study (IFCT-GFPC 0502) of Gemcitabine or Erlotinib Maintenance Therapy Versus Observation, With Predefined Second-Line Treatment, After Cisplatin-Gemcitabine Induction Chemotherapy in Advanced Non-Small-Cell Lung Cancer

  • Etude concernée: IFCT-0502
  • Auteurs / Authors: Pérol M, Chouaid C, Pérol D, Barlési F, Gervais R, Westeel V, Crequit J, Léna H, Vergnenègre A, Zalcman G, Monnet I, Le Caer H, Fournel P, Falchero L, Poudenx M, Vaylet F, Ségura-Ferlay C, Devouassoux-Shisheboran M, Taron M, Milleron B
  • Journal / Conference: Journal of Clinical Oncology
  • Année / Year: 2012
  • PMID: 22949150 
  • Lien vers la publication: https://www.ncbi.nlm.nih.gov/pubmed/22949150